Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Monday, June 1, 2026

Cooling Vest May Reduce Body Fat in Obesity

 Ask your competent? doctor  if THIS WILL SPECIFICALLY REDUCE VISCERAL FAT! No knowledge is grounds for firing!

Cooling Vest May Reduce Body Fat in Obesity

TOPLINE:

Daily cold exposure using cooling vests for 2 hours each morning over 6 weeks reduced body weight and body fat mass in adults with overweight or obesity. The intervention improved thermal comfort and cold-induced carbohydrate oxidation while reducing cold perception over time.

METHODOLOGY:

  • Cold exposure has gained attention as a possible way to decrease fat accumulation; however, previous studies involved lean participants or short-term interventions.
  • Researchers studied the effects of longer-term cold exposure in 47 adults with overweight or obesity (BMI, 25-35) who were randomly assigned either to the control group (n = 23) or the cold exposure group (n = 24). Participants wore a cooling vest and waist wrap with phase change material with 15 °C cooling pads for 2 hours each morning for 6 weeks.
  • Body composition was measured using bioimpedance and hepatic steatosis via FibroScan, and resting energy expenditure was evaluated at thermoneutrality (27 °C) and upon acute cold exposure (11 °C) before and after the intervention period.
  • Daily questionnaires assessed participants’ cold perception and thermal comfort.
  • Other measures included serum levels of glucose metabolism markers (eg, glucose and insulin) and lipid metabolism markers (eg, triglycerides, free fatty acids, total cholesterol, and low-density lipoprotein cholesterol), and whole blood was assessed for leukocyte count and lipopolysaccharide-induced cytokine release.

TAKEAWAY:

  • Compared with the control group, the cold exposure group had a reduced body weight by 1.6 ± 0.4 kg (P < .001) and BMI by 0.5 ± 0.1 (P < .001), attributed to a reduction in body fat mass of 1.5 ± 0.5 kg (P = .007), whereas fat-free mass remained unchanged.
  • Repeated cold exposure improved thermal comfort ratings of the cooling vest (P = .020) and decreased cold perception (P = .025).
  • Acute cold exposure enhanced cold-induced carbohydrate oxidation by 0.005 ± 0.002 g/min (P = .019).
  • Cold exposure did not result in changes in hepatic steatosis, circulating levels of markers related to glucose or lipid metabolism, leukocyte composition, or lipopolysaccharide-induced cytokine release in blood. 

IN PRACTICE:

“In subjects with overweight or obesity, 6 weeks of daily cold exposure reduced body weight primarily by lowering body fat mass,” the authors of the study wrote.

SOURCE:

The study was led by Mariëtte Boon, Department of Medicine, Division of Endocrinology, Leiden University Medical Center, Leiden, Netherlands. The findings were presented at the 33rd European Congress on Obesity (ECO) 2026.

No comments:

Post a Comment